US 11560379
Octahydro fused azadecalin glucocorticoid receptor modulators
granted A61PA61P35/00
Quick answer
US patent 11560379 (Octahydro fused azadecalin glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P35/00